The External Advisory Group (EAG) - also known as the Lambert Initiative Non-Executive Advisory Board - providies strategic guidance and external engagement opportunities.
The appointed members are influential in their fields and have a wealth of experience across a range of industries. The EAG is governed by Terms of Reference.
Deputy Vice-Chancellor (Research) and Professor of Political Philosophy, Duncan Ivison has research and teaching interests in contemporary political theory, the history of political thought and moral philosophy.
Prior to this role, he was Dean of the University of Sydney's Faculty of Arts and Social Sciences from 2010. He has also held appointments at the University of Toronto and the University of York.
As DVC Research, Professor Ivison is responsible for helping to develop and deliver the University’s research strategy, and supporting the pursuit of outstanding fundamental and applied research across the institution. His portfolio is responsible for commercialising research and facilitating partnerships with industry as well as providing access to University expertise, ideas and technologies for research and development
Professor Kathryn Refshauge is Dean of the Faculty of Health Sciences and Professor of Physiotherapy at the University of Sydney. She is a member of several boards and committees in the health sector, as well as various professional and research bodies. She has served on human research ethics committees and was involved in the Excellence in Research for Australia initiative.
Professor Refshauge was awarded the Vice-Chancellor’s Award for Excellence in Research Student Supervision in 2011 and a national award for Outstanding Contribution to Student Learning by the Australian Learning and Teaching Council in 2011. She holds several honorary professorial appointments and is a member of editorial board of international journals.
Carol Ireland is CEO and Managing Director of Epilepsy Action Australia. She has an extensive background spanning 35 years in the not-for-profit human services sector and has held a variety of executive positions in operations, service delivery, marketing and fundraising.
Carol currently serves on the Australian Advisory Council for the Use of Medicinal Cannabis and Steering Committee for the NSW government’s Paediatric Epilepsy Trials (Medicinal Cannabis Research). She is also a founding Director of the newly constituted Medicinal Cannabis Council.
In her role at Epilepsy Action she has had significant contact with many individuals and families who are faced with managing very challenging forms of medication resistant epilepsy, with few or no options left in the conventional treatment bucket.
Carol has heard and seen the changes in people’s lives, including reduction in the severity and frequency of seizures, resulting from use of medicinal cannabis. She is a strong and active advocate for people living with epilepsy.
Barry Lambert is a business man, medicinal cannabis advocate and philanthropist.
The Lambert Initiative is the outcome of an unprecedented pledge of $33.7 million by Barry and Joy Lambert to the University of Sydney in order to fund long-term research into the medicinal potential of the cannabis plant.
Barry is the Chairman of Ecofibre Limited which owns leading USA based Nutraceutical and Hemp producer Ananda Hemp.
Michael Lambert is the son of Barry and Joy Lambert, and the father of Katelyn. Read more about the Lambert Family here.
Professor Roger Pertwee’s research on cannabinoid pharmacology began in 1968 at Oxford University, and continued at Aberdeen University from 1974.
Professor Pertwee's achievements include the joint discovery of Δ9-tetrahydrocannabivarin in cannabis, and of endocannabinoids, the discovery of a CB1 receptor allosteric site, and the pharmacological characterization of phytocannabinoids and notable synthetic cannabinoids.
Professor Pertwee has served as IACM chairman, and twice as President of the ICRS.
Professor Michelle Glass is the Head of the Department of Pharmacology and Toxicology. The molecular pharmacologist had most recently been working at the University of Auckland for 18 years where she was Head of the Department of Pharmacology and in 2017 appointed Professor of Pharmacology.
Professor Glass worked as a postdoctoral Fellow in the Laboratory of Cellular and Molecular Regulation at the National Institute of Mental Health in Bethesda, Maryland for 18 months before moving on to work as a Visiting Fellow in the Laboratory of Cell Biology at the National Institute of Deafness and Other Communications Disorders in Rockville, Maryland. She returned to New Zealand in 2000 and took up a role as a Lecturer within the Department of Pharmacology at the University of Auckland.
Currently, Professor Glass is a member of the Medical Cannabis Research Collaborative (NZ), which aims to ensure robust clinical research of medical cannabis products in New Zealand is undertaken.
Dr. Spangenberg is Professor of Plant Genetics and Genomics with La Trobe University, and holds various other esteemed positions.
Dr Kathryn Sunn is an Intellectual Property and Commercialisation professional with a passionate focus on strategic growth and technology collaborations in the Medical and Life Sciences commercial arena. Dr Sunn has over 15 years of experience in the intellectual property sector and more than 7 years experience in the commercial, technology transfer space, having previously worked in several top tier Patent & Trade Mark Attorney and Law firms.
Dr Sunn gained her PhD in Medicine from the University of New South Wales in 2001 and her Masters of IP from the University of Technology, Sydney in 2002.
Professor Iain Young, in his capacity as Dean of the University of Sydney's Faculty of Science, is the head of one of the largest science organisations in Australia. With over 6,500 students and 26.1% and 18.6% of University research and teaching income respectively, the Faculty is large and complex in its structure.
Iain completed his BSc (Hons) at Aberdeen University in 1984, then obtaining a PhD in Soil Physics (1987) in the same institution. He then moved to The Scottish Crop Research Institution (SCRI) as a Research Leader in 1988 - now theJames Hutton Institute. Spending 12 years at SCRI, he became Head of the multidisciplinary Soil-Plant Dynamics group, before moving to Abertay University as the Founding Director and Professor of the Scottish Informatics Mathematics, Biology and Statistics (SIMBIOS) Centre. During Iain’s tenure at SIMBIOS, the group was assessed as in the top five research teams in Environmental science in the UK.
Professor Igor Grant, M.D., is Professor and Chair of the Department of Psychiatry at the University of California, San Diego School of Medicine. He is Director of the University of California Center for Medicinal Cannabis Research (CMCR), and Director of the HIV Neurobehavioral Research Program (HNRP), which includes the California NeuroAIDS Tissue Network (CNTN), the Translational Methamphetamine AIDS Research Center (TMARC), the HIV Neurobehavioral Research Center (HNRC), the CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER).
Dr. Grant is the founding Editor of the Journal of the International Neuropsychological Society and founding co-editor of the journal AIDS and Behavior.